PMID- 31409832 OWN - NLM STAT- MEDLINE DCOM- 20201118 LR - 20210110 IS - 2045-2322 (Electronic) IS - 2045-2322 (Linking) VI - 9 IP - 1 DP - 2019 Aug 13 TI - TNF-alpha promoter polymorphisms (G-238A and G-308A) are associated with susceptibility to Systemic Lupus Erythematosus (SLE) and P. falciparum malaria: a study in malaria endemic area. PG - 11752 LID - 10.1038/s41598-019-48182-5 [doi] LID - 11752 AB - Tumor necrosis factor-alpha (TNF-alpha) is a proinflammatory cytokine associated with autoimmune and infectious diseases. Importance of TNF-alpha in P. falciparum malaria and systemic lupus erythematosus (SLE) have been demonstrated. However, association of functional promoter variants with SLE and malaria is lacking in malaria endemic population. A total of 204 female SLE patients and 224 age and sex matched healthy controls were enrolled in the study. Three hundred fourteen P. falciparum infected patients with different clinical phenotypes were included. TNF-alpha polymorphisms (G-238A & G-308A) were genotyped by PCR-RFLP. Plasma levels of TNF-alpha was quantified by ELISA. Heterozygous mutants and minor alleles of TNF-alpha (G-238A and G-308A) polymorphisms were significantly higher in SLE patients compared to healthy controls and associated with development of lupus nephritis. In addition, both promoter variants were associated with severe P. falciparum malaria. SLE patients demonstrated higher levels of plasma TNF-alpha compared to healthy controls. TNF-alpha (G-238A and G-308A) variants were associated with higher plasma TNF-alpha. In conclusion, TNF-alpha (G-238A & G-308A) variants are associated with higher plasma TNF-alpha levels in SLE patients residing in malaria endemic areas and could be a contributing factor in the development of SLE and susceptibility to severe P. falciparum malaria. FAU - Mahto, Harishankar AU - Mahto H AD - Department of Bioscience and Bioinformatics, Khallikote University, GMax Building, Konisi, Berhampur, 761008, Odisha, India. AD - Centre for Life Sciences, Central University of Jharkhand, Brambe, Ranchi, 835205, Jharkhand, India. FAU - Tripathy, Rina AU - Tripathy R AD - Department of Biochemistry, S.C.B. Medical College, Cuttack, 753007, Odisha, India. FAU - Meher, Biswa Ranjan AU - Meher BR AD - Computational Biology and Bioinformatics Laboratory, Department of Botany, Berhampur University, Berhampur, Odisha, 760007, India. FAU - Prusty, Birendra K AU - Prusty BK AD - Infectious Disease Biology Group, Institute of Life Sciences, Bhubaneswar, Odisha, India. FAU - Sharma, Meenakshi AU - Sharma M AD - Centre for Life Sciences, Central University of Jharkhand, Brambe, Ranchi, 835205, Jharkhand, India. FAU - Deogharia, Divya AU - Deogharia D AD - Centre for Life Sciences, Central University of Jharkhand, Brambe, Ranchi, 835205, Jharkhand, India. FAU - Saha, Anjana Kumari AU - Saha AK AD - Centre for Life Sciences, Central University of Jharkhand, Brambe, Ranchi, 835205, Jharkhand, India. FAU - Panda, Aditya K AU - Panda AK AD - Department of Bioscience and Bioinformatics, Khallikote University, GMax Building, Konisi, Berhampur, 761008, Odisha, India. adityarmrc@gmail.com. AD - Centre for Life Sciences, Central University of Jharkhand, Brambe, Ranchi, 835205, Jharkhand, India. adityarmrc@gmail.com. FAU - Das, Bidyut K AU - Das BK AD - Department of Medicine, S.C.B. Medical College, Cuttack, 753007, Odisha, India. bidyutdas@hotmail.com. LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't DEP - 20190813 PL - England TA - Sci Rep JT - Scientific reports JID - 101563288 RN - 0 (Tumor Necrosis Factor-alpha) SB - IM MH - Adult MH - Endemic Diseases MH - Female MH - *Genetic Predisposition to Disease MH - Humans MH - Lupus Erythematosus, Systemic/*genetics MH - Malaria, Falciparum/epidemiology/*genetics MH - Male MH - Middle Aged MH - *Polymorphism, Genetic MH - *Promoter Regions, Genetic MH - Tumor Necrosis Factor-alpha/*genetics PMC - PMC6692415 COIS- The authors declare no competing interests. EDAT- 2019/08/15 06:00 MHDA- 2020/11/20 06:00 PMCR- 2019/08/13 CRDT- 2019/08/15 06:00 PHST- 2018/01/26 00:00 [received] PHST- 2019/07/26 00:00 [accepted] PHST- 2019/08/15 06:00 [entrez] PHST- 2019/08/15 06:00 [pubmed] PHST- 2020/11/20 06:00 [medline] PHST- 2019/08/13 00:00 [pmc-release] AID - 10.1038/s41598-019-48182-5 [pii] AID - 48182 [pii] AID - 10.1038/s41598-019-48182-5 [doi] PST - epublish SO - Sci Rep. 2019 Aug 13;9(1):11752. doi: 10.1038/s41598-019-48182-5.